Australia markets closed

Genetic Technologies Limited (GENE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.3700+0.0500 (+2.16%)
At close: 04:00PM EDT
2.4200 +0.05 (+2.11%)
After hours: 06:26PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 10.19M
Enterprise value 8.04M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.60
Price/book (mrq)3.30
Enterprise value/revenue 0.95
Enterprise value/EBITDA -0.67

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 3-55.28%
S&P500 52-week change 323.06%
52-week high 35.9000
52-week low 31.8000
50-day moving average 32.5388
200-day moving average 33.1955

Share statistics

Avg vol (3-month) 330.52k
Avg vol (10-day) 336.88k
Shares outstanding 54.41M
Implied shares outstanding 624.81M
Float 8101.76M
% held by insiders 10.00%
% held by institutions 10.56%
Shares short (28 Mar 2024) 411.53k
Short ratio (28 Mar 2024) 40.27
Short % of float (28 Mar 2024) 4N/A
Short % of shares outstanding (28 Mar 2024) 40.30%
Shares short (prior month 29 Feb 2024) 460.14k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 315 Aug 2019
Ex-dividend date 4N/A
Last split factor 21:5
Last split date 314 Dec 2023

Financial highlights

Currency in AUD.

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -124.08%
Operating margin (ttm)-105.96%

Management effectiveness

Return on assets (ttm)-52.71%
Return on equity (ttm)-160.47%

Income statement

Revenue (ttm)10.24M
Revenue per share (ttm)2.73
Quarterly revenue growth (yoy)-2.10%
Gross profit (ttm)N/A
EBITDA -9.86M
Net income avi to common (ttm)-12.71M
Diluted EPS (ttm)-0.1500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.73M
Total cash per share (mrq)0.03
Total debt (mrq)382.32k
Total debt/equity (mrq)7.95%
Current ratio (mrq)1.67
Book value per share (mrq)0.04

Cash flow statement

Operating cash flow (ttm)-7.6M
Levered free cash flow (ttm)-4.6M